Simplex Trading’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Simplex Trading's RXRX Position: Q3 2026 in Review
Simplex Trading increased its Recursion Pharmaceuticals (RXRX) stake by 57% in Q3 2026, buying an estimated $319K and bringing the position to 257,685 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2658.
Simplex Trading first reported a position in RXRX in Q2 2021 and has held it in 17 quarters since. The position peaked at $2.54M in Q1 2025. 347 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- Simplex Trading held 257,685 shares of Recursion Pharmaceuticals worth $1.06M as of Q3 2026.
- Simplex Trading bought 93,999 Recursion Pharmaceuticals shares in Q3 2026, an estimated $319K.
- Recursion Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #2658 holding.
- Simplex Trading first reported a position in Recursion Pharmaceuticals in Q2 2021 and has held it in 17 quarters since.
- Simplex Trading's Recursion Pharmaceuticals position peaked at $2.54M in Q1 2025.
- 347 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.